The FDA Bad Ad Program and Prescription Drug Promotion
About This Site:
This activity is supported by the U.S. Food and Drug Administration (FDA) through a contract from the U.S. Department of Health and Human Services, and FDA's privacy policies apply while you are on this site.
Target Audience:
The target audience for this course is healthcare professionals, including physicians, physician assistants, nurses, nurse practitioners, pharmacists, and pharmacy technicians.
Description:
This activity will educate a national audience of healthcare professionals about the FDA Bad Ad program. It will also educate the nation's healthcare professionals about prescription drug advertising and promotion.
Learning Objectives:
Upon completion of this activity, participants will be able to:
- Identify the role that FDA’s Office of Prescription Drug Promotion, or OPDP, plays in regulating prescription drug promotion and advertising.
- Recognize persuasive techniques commonly used in advertising and promotion.
- Describe the most common regulatory issues raised by prescription drug promotion.
- Recognize potentially false or misleading prescription drug promotion.
- Locate the Bad Ad contact information.
- Translate knowledge into action and report potentially problematic prescription drug promotion to OPDP.
Acknowledgement of Financial Commercial Support:
No financial commercial support was received for this educational activity.
Acknowledgement of In-Kind Commercial Support:
No in-kind commercial support was received for this educational activity.
Disclosure Information
The following table of disclosure information is provided to learners and contains the relevant financial relationships of each individual in a position to control the content of the course. All of these relationships were treated as a conflict of interest; and have been resolved. (C7 SCS 6.1--6.2, 6.5).
| First Name | Last Name | Disclosure |
|---|---|---|
| Robert | Dean | Nothing to disclose |
| Elaine | Frost | Nothing to disclose |
| Ankur | Kalola | Nothing to disclose |
| Jina | Kwak | Nothing to disclose |
| Hailey | Lee | Nothing to disclose |
| Sophia | Ni | Nothing to disclose |
| Meeta | Patel | Nothing to disclose |
| Elizabeth | Pepinsky | Nothing to disclose |
| Meena | Savani | Nothing to disclose |
| Rachel | Shaw | Nothing to disclose |
Handouts and Resources:
Technical Requirements and Instructions:
To access the course, users will need a computer with an Internet connection, and:
- Internet Explorer 10 or higher,
- Firefox 43 or higher,
- Safari 9 or higher, or
- Any other W3C standards compliant browser
An HTML5 capable browser is required for video playback. Occasionally, other additional software may be required such as Microsoft PowerPoint or Adobe Acrobat Reader. Viewing on a desktop, laptop, or tablet is recommended.
Please note that the preload and autoplay function for videos and audios is disabled for iOS devices using Safari on cellular networks, and requires a manual playback using the onscreen controls. For additional information, please refer to Apple's Safari HTML 5 Audio and Video Guide.
For questions about content or about technical issues, you may contact FDA:
Toll Free
(855) 543-3784, or
(301) 796-3400
druginfo@fda.hhs.gov